1. Editorial

   EditorialNotes Pages: 3 - 3

2. The surgeon's role in breast cancer: Changing concepts

   • Henry Patrick Leis Jr.

   Viewpoints Pages: 5 - 15

3. A commentary on the role of the surgeon in primary breast cancer

   • Bernard Fisher

   Viewpoints Pages: 17 - 26

4. The surgeon's role in primary breast cancer

   • John Hayward

   Viewpoints Pages: 27 - 32

5. Estrogen receptor measurement in low-protein breast cancer cytosols

   • Bernard L. Powell
   • Minerva De La Garza
   • William L. McGuire

   Viewpoints Pages: 33 - 35

6. Correlation of primary breast cancer histopathology and estrogen receptor content

   • Edwin R. Fisher
   • C. Kent Osborne
   • Houston C. Ford

   Reports Pages: 37 - 41

7. The interpretation of trials: Combined hormonal therapy and chemotherapy in disseminated breast cancer

   • Stephen K. Carter

   US-Japan Conference on Chemoendocrine Therapy Pages: 43 - 51

8. Tamoxifen alone versus tamoxifen plus 1-(2-tetrahydrofuryl)-5-fluorouracil in the treatment of advanced breast cancer: A sequential trial

   • Tomio Wada
   • Hiroki Koyama
   • Toshio Terasawa

   US-Japan Conference on Chemoendocrine Therapy Pages: 53 - 58

9. Randomized clinical trial of tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal women with advanced breast cancer

   • John H. Glick
   • Richard H. Creech
   • Michael Varano

   US-Japan Conference on Chemoendocrine Therapy Pages: 59 - 68

10. Adjuvant chemo-endocrine therapy for androgen-dependent mammary tumor in mice

    • Naomi Uchida
    • Kenji Yamaguchi
    • Keishi Matsumoto

    US-Japan Conference on Chemoendocrine Therapy Pages: 69 - 75

11. Adjuvant therapy of stage II breast cancer

    • Charles A. Hubay
    • Olof H. Pearson
    • 27 Participating Investigators

    US-Japan Conference on Chemoendocrine Therapy Pages: 77 - 82

12. National meeting on breast cancer

    Announcements Pages: 83 - 83

13. List of forthcoming papers

    Legacy Pages: 85 - 85